Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor
Abstract Krabbe disease (KD) and metachromatic leukodystrophy (MLD) are caused by accumulation of the glycolipids galactosylceramide (GalCer) and sulfatide and their toxic metabolites psychosine and lysosulfatide, respectively. We discovered a potent and selective small molecule inhibitor (S202) of...
Enregistré dans:
Auteurs principaux: | Michael C. Babcock, Christina R. Mikulka, Bing Wang, Sanjay Chandriani, Sundeep Chandra, Yue Xu, Katherine Webster, Ying Feng, Hemanth R. Nelvagal, Alex Giaramita, Bryan K. Yip, Melanie Lo, Xuntian Jiang, Qi Chao, Josh C. Woloszynek, Yuqiao Shen, Shripad Bhagwat, Mark S. Sands, Brett E. Crawford |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b4baa35aa3c440d78cac8c75d11ceb69 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Four novel ARSA gene mutations with pathogenic impacts on metachromatic leukodystrophy: a bioinformatics approach to predict pathogenic mutations
par: Dehghan Manshadi M, et autres
Publié: (2017) -
Late-Onset Leukodystrophy Mimicking Hereditary Spastic Paraplegia without Diffuse Leukodystrophy on Neuroimaging
par: Zhang T, et autres
Publié: (2021) -
Central nervous system pathology progresses independently of KC and CXCR2 in globoid-cell leukodystrophy.
par: Adarsh S Reddy, et autres
Publié: (2014) -
National U.S. Patient and Transplant Data for Krabbe Disease
par: Gabrielle Ghabash, et autres
Publié: (2021) -
A hypomyelinating leukodystrophy in German Shepherd dogs
par: Pia R. Quitt, et autres
Publié: (2021)